摘要
他汀类药物作为一类经典和有效的降脂药物,在肾脏疾病的治疗中已得到广泛应用,具有保护肾小球、肾小管、减少肾移植排异反应、降低晚期肾脏疾病病人冠心病发病率和死亡率等作用。本文对近年来他汀类药物在肾脏疾病的研究综述如下。
出处
《河南职工医学院学报》
2005年第2期124-126,共3页
Journal of Henan Medical College For Staff and Workers
参考文献15
-
1Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuriaand urinary podocytes in patients with chronic glomrulonephritis[J]. Nephrol Dial Transplant,2002,17(5):798 ～ 802
-
2van den Akker JM, Bredie SJ, Diepenveen SH, et al. Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL[J] .J Nephrol, 2003 Mar-Apr,16(2) :44 ～ 238
-
3Wheeler DC.Are there potential non-lipid-lowering uses of statins[J].Drugs, 1998,56(4) :517 ～ 522
-
4Zoja C, Corna D, Rottoli D, et al. Effect of combining ACE inhibitor and statin in severe experiment [ J]. Kidney Int, 2002,61 (5): 1 635 ～1 645
-
5Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth factor-β1 exprssion in diabetic rat glomeruli and cultured rat mesangial cells[J] .J Am Soc Nephrol,2000,11:80 ～ 87
-
6Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant ,2003,18:265 ～ 271
-
7Park JK, Muller DN, Mervaala EM. Cerivastatin prevents angiotensin Ⅱ induced renal injury independent of blood pressure-and cholesterollowering effects[J]. Kidney Int,2000,58[4]: 1 420 ～ 1 430
-
8Jandeleit-Dahm K,Cao Z,Cox AJ,et al. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy [ J ]. Kidney Int,1999,56 (Suppl 71) :S31 ～ 64
-
9Yokota N, O' Donnell M, Daniels F, et al. Protective effect of HMGCoA reductase inhibitor on experimental renal ischemia-reperfusion injury[J] .Am J Nephrol,2003,23(1): 13 ～ 17
-
10Jin-Song HE, Satoshi HORIKOSHI, Kazuhiko FUNABIKI, et al. Effects of atorvastatin on ischemic acute renal failure in aging rats [ J ].Nephrology, 2002,7: 83 ～ 86
同被引文献15
-
1吴智鸿,赵水平.他汀类药物抗骨质疏松作用的研究进展[J].中华老年医学杂志,2005,24(1):64-66. 被引量：11
-
2Ooi SY,Ball SG.Statins and rheumatoid arthritis. The Lancet . 2004
-
3Attallah N,Yassine L,Musial,et al.The potential role of statins incontrast nephropathy. C lin Nephrol . 2004
-
4Stefan SleijferAte,van derGaast,,Andre′S.Th.et al.The poten-tial of statins as part of anti-cancer treatm ent. European Journal of Cancer . 2005
-
5Lee KT,LaiWT,Chu CS,et al.E ffect ofw ithdrawal of statin on C-reactive protein. Cardiology . 2004
-
6M ichael J Gonyeau.Statins and Osteoporosis:A C lin icalReview. Pharmacotherapy . 2005
-
7Chan KY,Boucher ES,Gandh i PJ E t al.HMG-CoA reductase in-h ib itors for lowering elevated levels of C-reactive protein. American Journal of Health System Pharmacy . 2004
-
8F ield KM.E ffect of 3-hydroxy-3-m ethylglutaryl coenzym e a reduc-tase inh ib itors on h igh-sensitivity C-reactive protein levels. Phar-macotherapy . 2005
-
9R idker PM,Caannon CP,Morrow D,et al.C-reactive protein levelsand outcom es after statin therapy. The New England Journal of Medicine . 2005
-
10Agarwal R,Curley TM.The role of statins in chron ic k idney d is-ease. Am JM ed Sci . 2005
-
1FDA批准一种新的克服肾移植排异反应的方案[J].世界临床药物,2003,24(6):323-323.
-
2池小月,倪乐乐,王小丽.注射用丁二磺酸腺苷蛋氨酸与注射用甲泼尼龙琥珀酸钠存在配伍禁忌[J].全科护理,2012,10(7):670-670. 被引量：1
-
3汤华琴,申斌.抗肾移植排异反应新药——Nulojix[J].齐鲁药事,2011,30(10):619-620. 被引量：1
-
4孙志强,靳胜燕.来氟米特的不良反应[J].中原医刊,2006,33(23):52-52. 被引量：12
-
5李淑慧,李晓辉.新型免疫抑制药物霉酚酸酯与他克罗姆的研究进展[J].中国药业,2002,11(2):41-42. 被引量：4
-
6汪静雪,李怡凡,邵黎,丁桂凤,范少光.纳曲酮对移植排异反应的抑制作用[J].中华微生物学和免疫学杂志,1997,17(2):107-110. 被引量：2
-
7孙成春,郝俊文.肾移植后监测环孢素A血药浓度与β2－微球蛋白的临床意义[J].中国医院药学杂志,1996,16(11):488-490. 被引量：2
-
8澳发现肝脏移植排异反应低的机理[J].中华中医药学刊,2013,31(10):2209-2209.
-
9美国：简单血液测试可发现器官移植排异反应[J].健康大视野,2010(20):6-6.
-
10张小波,王莘.来氟米特的临床应用[J].天津药学,2011,23(4):64-67. 被引量：4
